| Literature DB >> 22312315 |
Kyoung Mi Moon1, Ye-Hyoung Park2, Jae Seol Lee1, Yong-Byung Chae3, Moon-Moo Kim3, Dong-Soo Kim2, Byung-Woo Kim4, Soo-Wan Nam1,4,5, Jong-Hwan Lee1,4,5.
Abstract
UNLABELLED: The beneficial effects of adipose-derived stem cell conditioned medium (ADSC-CM) on skin regeneration have been reported. Although the mechanism of how ADSC-CM promotes skin regeneration is unclear, ADSC-CM contained various growth factors and it is an excellent raw material for skin treatment. ADSC-CM produced in a hypoxia condition of ADSC-in other words, Advanced Adipose-Derived Stem cell Protein Extract (AAPE)-has great merits for skin regeneration. In this study, human primary keratinocytes (HKs), which play fundamental roles in skin tissue, was used to examine how AAPE affects HK. HK proliferation was significantly higher in the experimental group (1.22 μg/mL) than in the control group. DNA gene chip demonstrated that AAPE in keratinocytes (p < 0.05) notably affected expression of 290 identified transcripts, which were associated with cell proliferation, cycle and migration. More keratinocyte wound healing and migration was shown in the experimental group (1.22 μg/mL). AAPE treatment significantly stimulated stress fiber formation, which was linked to the RhoA-ROCK pathway. We identified 48 protein spots in 2-D gel analysis and selected proteins were divided into 64% collagen components and 30% non-collagen components as shown by the MALDI-TOF analysis. Antibody array results contained growth factor/cytokine such as HGF, FGF-1, G-CSF, GM-CSF, IL-6, VEGF, and TGF-β3 differing from that shown by 2-D analysis.Entities:
Keywords: AAPE; ADSC-CM; RhoA-ROCK signaling; migration; proliferation; regeneration; stress fiber formation
Mesh:
Substances:
Year: 2012 PMID: 22312315 PMCID: PMC3269749 DOI: 10.3390/ijms13011239
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1Human Keratinocyte (HK) proliferation. The amount of HK keratinocyte is represented by the cell proliferation (%) in the MTS assay (n = 3). There was an increase in HK proliferation in the groups ranging from 0 to 1.25 μg/mL concentration. The values are expressed as the mean ± SD and values containing asterisks differ significantly from the control group as shown by one-way analysis of variance (ANOVA, Systat Software, Inc.) (* p < 0.05).
Figure 2DNA chip analysis. Functional classes of differentially regulated genes in keratinocyte incubated with Advanced Adipose-Derived Stem cell Protein Extract (AAPE). Regulated genes were grouped into nine functional categories and graphed as a percentage of the total, based on their GeneGo designation. 290 genes were differentially regulated based on analysis of the array data (A). Of the regulated genes, 243 were up-regulated (B) and 53 were down-regulated (C). A number of down-regulated genes (12) are associated with cell adhesion; none of the genes in this category were up-regulated. The DNA replication-related transcript category contained 0 down-regulated genes and 42 up-regulated genes. In the cell cycle category, a notable difference in the number of transcripts down-regulated (4) and up-regulated (100) related to cell cycle was observed.
Figure 3Scratch wound healing assay (n = 3) and transwell migration assay (n = 3) of keratinocyte in response to AAPE. (A) Cells were cultured in keratinocyte culture medium and wound line was created by microtip. After then, cells were incubated with AAPE (1.22 μg/mL) for 24 h. After 24 h, the width of the gaps made by scratching decreased more in the AAPE administered group (AAPE) than in the control group (Medium) or Y27632 treated group (Y27632), Original magnification × 100. (B) The percentage signifies the remnant gap size 24 h after making scratches, compared to the initial gap size. The gap width decreased more in the AAPE treated group than in the control group (n = 5). (C) Chemotactic migration of keratinocytes toward AAPE. Chemotactic activity was determined by constant-period counting using a flow cytometer and is shown as mean ± SD by one-way ANOVA’s t-test. Keratinocytes exhibit typical chemotaxis toward AAPE (1.22 μg/mL), and keratinocyte chemotaxis is dependent on ROCK activity (Y27632+AAPE). Values are expressed as the mean ± SD and asterisk values are significant compared to the control group by one way ANOVA’s test (* p < 0.05).
Figure 4Inhibition of ROCK prevents AAPE-induced actin stress fiber formation. HK was left untreated or challenged for 1 h with AAPE (1.22 μg/mL) in the absence or presence of 10 μM Y27632. The cells were then fixed, permeabilized, and stained with rhodamine phalloidin to visualize the actin stress fibers by fluorescence microscopy. The results are representative of three experiments.
Figure 5RhoA-ROCK activity is associated with phosphorylation of cofilin in HK. RhoA pull down assay and Western blot were performed for detection of active RhoA (A) and AAPE, Y27632+AAPE and control HK were assessed by Western blot for cofilin and p-cofilin (B). The Western blot membrane was normalized for GAPDH to control loading.
Figure 62-D gel analysis of protein samples. Silver-stained 2-D maps of AAPE (A,B), collagen (C) and fibronetin (D). Red circle (A) and numbered spots (B) indicate the proteins excised for identification by MS.
Proteins identified from spots by Mascot search of the NCBInr database (Collagen).
| Trypsin spot | Protein name | Accession # | Protein score | Pep. count | Position | Sequence coverage |
|---|---|---|---|---|---|---|
| 303 | Type VI collagen, alpha-2, isoform 2C2a’ | NP_478055 | 86 | 9 | 96–393 | 12% |
| 304 | Human pro alpha 1(I) collagen | CAA29605 | 138 | 7 | 9–196 | 45% |
| 305 | Type VI collagen, alpha-1 chain | CAA33888 | 210 | 11 | 52–256 | 50% |
| 404 | Type VI collagen, alpha-1 C-terminal domain | CAA33888 | 155 | 8 | 69–211 | 39% |
| 405 | Type VI collagen, alpha-1 C-terminal domain | CAA33888 | 162 | 9 | 52–256 | 41% |
| 1302 | Type VI collagen, alpha 2, isoform | EAX09316 | 103 | 9 | 96–411 | 12% |
| 1303 | Human pro alpha 1(I) collagen | CAA29605 | 142 | 11 | 9–196 | 48% |
| 1304 | Type VI collagen, alpha-1 C-terminal | CAA33888 | 288 | 16 | 28–256 | 67% |
| 1305 | Carboxy-propeptide of alpha 1 (III) procollagen | CAA25879 | 150 | 11 | 1–211 | 45% |
| 1307 | Carboxy-propeptide of alpha 1 (III) procollagen | CAA25879 | 41 | 3 | 46–52 | 18% |
| 2302 | Carboxy-propeptide of alpha 1 (III) procollagen | CAA25879 | 179 | 13 | 1–211 | 43% |
| 2303 | Type VI collagen, alpha-1 C-terminal domain | CAA33888 | 139 | 8 | 52–256 | 30% |
| 2401 | Type I collagen | CAA39142 | 120 | 9 | 165–361 | 25% |
| 2403 | Human pro alpha 1(I) collagen | CAA29605 | 129 | 7 | 9–196 | 45% |
| 2404 | Carboxy-propeptide of alpha 1 (III) procollagen | CAA25879 | 213 | 13 | 43–211 | 47% |
| 3302 | Type I collagen | CAA39142 | 137 | 12 | 165–361 | 29% |
| 3401 | Type I collagen | CAA39142 | 147 | 12 | 165–361 | 29% |
| 3403 | Carboxy-propeptide of alpha 1 (III) procollagen | CAA25879 | 175 | 12 | 43–211 | 44% |
| 3404 | Pro alpha 1(I) collagen | CAA29605 | 85 | 7 | 9–171 | 37% |
| 3405 | Pro alpha 1(I) collagen | CAA29605 | 90 | 8 | 9–171 | 30% |
| 3406 | Type I collagen | CAA39142 | 127 | 9 | 165–361 | 25% |
| 3503 | Type VI collagen, alpha-1 | CAA33889 | 114 | 9 | 91–431 | 23% |
| 3505 | Type VI collagen, alpha-1 | CAA33889 | 148 | 12 | 101–432 | 27% |
| 3509 | Type VI collagen, alpha-1 | CAA33889 | 187 | 13 | 91–432 | 30% |
| 3510 | Type VI collagen, alpha-1 | CAA33889 | 94 | 7 | 120–431 | 20% |
| 3513 | Type VI collagen, alpha-1 | CAA33889 | 97 | 8 | 120–431 | 21% |
| 5403 | Pro alpha 1(I) collagen | CAA29605 | 133 | 10 | 9–196 | 49% |
| 5501 | Type VI collagen, alpha-1 | CAA33889 | 208 | 14 | 91–432 | 31% |
| 6301 | Type I collagen | CAA39142 | 217 | 16 | 165–361 | 41% |
| 6401 | Type I collagen | CAA39142 | 164 | 14 | 165–361 | 29% |
| 6502 | Type VI collagen, alpha-1 | CAA33889 | 134 | 10 | 120–431 | 27% |
| 407 | Human Plasminogen Activator Inhibitor Type-1 | 1A7C_A | 182 | 15 | 1–379 | 42% |
| 705 | Gelatinase A | 1CK7_A | 185 | 18 | 1–631 | 34% |
| 707 | Gelatinase A | 1CK7_A | 249 | 23 | 1–561 | 47% |
| 708 | Gelatinase A | 1CK7_A | 247 | 21 | 1–561 | 40% |
| 2201 | Connective tissue growth factor precursor | NP_001892 | 77 | 5 | 43–152 | 14% |
| 2203 | Interleukin-6 precursor | NP_000591 | 96 | 5 | 59–207 | 22% |
| 2405 | Human procathepsin L | 1CJL_A | 97 | 6 | 18–292 | 23% |
| 3201 | Cadherin 2, isoform | EAX01239 | 64 | 6 | 34–114 | 8% |
| 4201 | Heparan sulfate proteoglycan 2 | EWA94994 | 67 | 11 | 181–3588 | 3% |
| 5201 | Prommp-2TIMP-2 | 1GXD_C | 62 | 4 | 28–194 | 19% |
| 6201 | SPAG9 protein | AAI06049 | 70 | 7 | 1–461 | 21% |
| 6213 | Prommp-2TIMP | 1GXD_C | 68 | 5 | 28–194 | 23% |
| 6214 | Prommp-2TIMP | 1GXD_C | 89 | 7 | 28–194 | 30% |
| 6505 | Chain A of human PEDF | 1IMV_A | 141 | 10 | 34–391 | 24% |
| 7501 | Chain A of human PEDF | 1IMV_A | 161 | 13 | 34–398 | 30% |
| 1403 | N/I | |||||
| 3304 | N/I | |||||
| 5402 | N/I |
: Not determined.
Figure 7Antibody array of AAPE. (A) AAPE was subjected to antibody array. Portions of the array illustrating the differential expression of proteins between control and HGF antibody are shown. Each panel contains six replicates of a specific antibody-protein reaction. (B) Quantitation of the average signal for each protein between samples. Heat map were analyzed by Genowiz 4.0TM as described in Materials and Methods. The median streptavidin–Cy3 fluorescence from all microsphere subsets was exported. The heat map shows antibody reactivity intensity (i.e., values above HGF) as red pixels and (values below HGF) as green pixels.